Coherus Oncology (CHRS) FCF Margin (2013 - 2026)
Coherus Oncology (CHRS) reported FCF Margin of -433.98% for Q2 2026, down 4693.47 percentage points from 4259.49% a year earlier but up 36.25 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) FCF Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Coherus Oncology's FCF Margin came in at -381.67%, down 1560.05 percentage points year-over-year; for FY2025, it was 786.76%, up 0.89 percentage points from FY2024.
- FCF Margin has increased for three consecutive years, with a five-year change of +755.88 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at 785.87% in FY2024 (+853.96 pp), -68.09% in FY2023 (+47.13 pp), -115.22% in FY2022 (-103.36 pp) and -11.86% in FY2021 (-42.73 pp).
- Five-year quarterly FCF Margin spans a low of -1024.72% in Q3 2024 and a high of 6111.66% in Q1 2024.
- Year over year, FCF Margin has now declined in each of the last three quarters, with an average year-over-year change of -1064.80 percentage points over the last eight quarters.
- The high point for year-over-year FCF Margin in five years was Q1 2024 (a gain of 6324.02 percentage points); the low point was Q1 2025 (a drop of 6513.62 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -470.24% (Q1 2026), -220.36% (Q4 2025) and -400.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.01% |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | -433.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -433.98% |
| Mar 31, 2026 | -470.24% |
| Dec 31, 2025 | -220.36% |
| Sep 30, 2025 | -400.48% |
| Jun 30, 2025 | 4,259.49% |
| Mar 31, 2025 | -401.96% |
| Dec 31, 2024 | 369.95% |
| Sep 30, 2024 | -1,024.72% |
| Jun 30, 2024 | 968.67% |
| Mar 31, 2024 | 6,111.66% |
| Dec 31, 2023 | -14.17% |
| Sep 30, 2023 | -72.82% |
| Jun 30, 2023 | -66.45% |
| Mar 31, 2023 | -212.37% |
| Dec 31, 2022 | -220.59% |
| Sep 30, 2022 | -82.66% |
| Jun 30, 2022 | -84.65% |
| Mar 31, 2022 | -90.93% |
| Dec 31, 2021 | -71.97% |
| Sep 30, 2021 | 16.30% |
API Access
Coherus Oncology FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();